Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Microbot MedicalMBOT +3.50%29 6-1 Month Momentum % is 8.33% as of Aug. 03, 2026. GuruFocus rates MBOT with a GF Score™ of 29/100. The stock has 2 warning signs investors should review. Among 847 Medical Devices & Instruments companies, Microbot Medical ranks better than 80.87% on this metric.
6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2026-08-03), Microbot Medical's 6-1 Month Momentum % is 8.33%.
The industry rank for Microbot Medical's 6-1 Month Momentum % or its related term are showing as below:
MBOT's 6-1 Month Momentum % is ranked better than 80.87% of 847
companies
in the Medical Devices & Instruments industry
Industry Median: -14.18
vs MBOT: 8.33
Microbot Medical (NAS:MBOT) 6-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Microbot Medical 6-1 Month Momentum % Related Terms
MBOT vs STXS, DXR, KRMD: 6-1 Month Momentum % Comparison
For the Medical Instruments & Supplies subindustry, Microbot Medical's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microbot Medical 6-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Microbot Medical's 6-1 Month Momentum % falls into.
Microbot Medical (NAS:MBOT) 6-1 Month Momentum % Calculation
6-1 Month Momentum % is calculated as following:
6-1 Month Momentum %
=
( Price 1-month ago
/
Price 6-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microbot Medical (MBOT) has a 6-1 Month Momentum % of 8.33% as of Aug. 03, 2026. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on Microbot Medical and its competitors. According to the industry distribution chart, Microbot Medical ranks #162 out of 847 companies in the Medical Devices & Instruments industry, placing it in the top 19.1%.
Is Microbot Medical's 6-1 Month Momentum % too high?
Microbot Medical's current 6-1 Month Momentum % is 8.33%. Based on the distribution chart, Microbot Medical ranks #162 out of 847 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Microbot Medical has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Microbot Medical's 6-1 Month Momentum % compare to STXS and DXR?
According to the Medical Devices & Instruments industry distribution chart, Microbot Medical ranks #162 out of 847 companies for 6-1 Month Momentum %. This places Microbot Medical in the top 19% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-1 Month Momentum % for a Medical Devices & Instruments company?
A good 6-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 6-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-1 Month Momentum % mean?
A high 6-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on Microbot Medical and its competitors. Microbot Medical's current 6-1 Month Momentum % is 8.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbot Medical stock overvalued right now?
Microbot Medical (MBOT) has a current 6-1 Month Momentum % of 8.33%. The current 6-1 Month Momentum % is 8.33%. Microbot Medical's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-1 Month Momentum % calculated?
6-1 Month Momentum % is calculated from a company's financial statements. For Microbot Medical (MBOT), the current 6-1 Month Momentum % is 8.33% as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
29GF Score
Get the complete analysis for MBOT
6-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MBOT has been successfully added to your 
